Texting support for Latina breast cancer patients on hormone therapy
Part of Cancer clinical trials.
This study tests if a text message program can help Latina breast cancer patients remember to take their hormone therapy pills. It also looks at how non-medical challenges (like money or housing issues) affect medication taking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Latina woman aged 18 or older.
- You have hormone receptor-positive breast cancer and are taking hormone therapy (like tamoxifen or an aromatase inhibitor).
- You started your hormone therapy 1 to 24 months ago.
- You are experiencing any non-medical challenge (like trouble paying for medicine, lack of transportation, or unstable housing).
- You can read and have a smartphone with text messaging and internet access.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mobile health program to help women manage symptoms and stay healthy while taking hormone therapy (like tamoxifen or anastrozole) for early-stage breast cancer. It involves using a smartphone app and an electronic pill bottle to track your health and medication.
This study tests whether text message reminders help women with early-stage, hormone-sensitive breast cancer remember to take their daily cancer-prevention medication. The goal is to see if reminders improve how consistently women take their pills, which can help prevent cancer from coming back.
This trial supports Latina women who have higher breast cancer risk and face added barriers (like cost, transportation, safety, or isolation) to get recommended breast screening and genetic risk information. It aims to help you understand your risk and access care when it’s due.
This study tests a program that uses text messages and a personal health coach to help Latino men with HIV take their medication every day. It's designed for those who have had trouble sticking to their HIV medicine routine.
This study will test if a smartphone program and social media group can help Hispanic/Latino teens and young adults who had childhood cancer become more physically active. You would wear a Fitbit and use a phone app with culturally tailored tips and support.
This trial tests a smartphone app called Sidekick to help women with early-stage breast cancer stick to their hormone therapy and feel more confident managing their health. If you were diagnosed with stage I, II, or III breast cancer after September 2023 and are starting hormone therapy, this program might help you stay on track.
Hear when a new Treatment Adherence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.